Alina Bencia
Director of Investor Relations, Experian Therapeutics
Replay available
Esperion Therapeutics, Inc. (ESPR) Q3 2024 Earnings Call
Esperion Therapeutics, Inc. (NASDAQ: ESPR) Q3 2024 earnings conference call, held 2024-11-07. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Sheldon Koenig
President and CEO
Ben Halliday
CFO
Dennis Ng
Analyst, Jefferies
Serge Belanger
Analyst, Needham
Jason Zeminski
Analyst, Bank of America
Tom Schrader
Analyst, PTIG
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Esperion Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:01.138 -- 00:00:04.659 Ladies and gentlemen, thank you for standing by and welcome. 00:00:04.659 -- 00:00:07.980 At this time, all participants are in listen-only mode. 00:00:07.980 -- 00:00:11.302 Following the presentation, there will be a question and answer session. 00:00:11.302 -- 00:00:13.843 Please be advised that today's conference call may be recorded. 00:00:13.843 -- 00:00:18.784 I'd like to hand the conference over to Alina Bencia, Director of Investor Relations 00:00:18.784 -- 00:00:22.465 for Experian Therapeutics. Please go ahead. 00:00:26.291 -- 00:00:31.635 Thank you, operator. Good morning, and welcome to Experian's third quarter 2024 earnings 00:00:31.635 -- 00:00:36.779 conference call. With us today are Sheldon Koenig, president and CEO, 00:00:36.779 -- 00:00:39.101 and Ben Halliday, CFO. 00:00:39.101 -- 00:00:43.704 Other members of the executive team will be available for Q&A following our prepared 00:00:43.704 -- 00:00:48.988 remarks. We issued a press release earlier this morning detailing the content of today's 00:00:48.988 -- 00:00:54.292 call. A copy can be found on the investor page of our website, together with a copy 00:00:54.292 -- 00:00:57.951 of the presentation that we will also be referencing. 00:00:57.951 -- 00:01:02.275 I want to remind callers that the information discussed on the call today is covered 00:01:02.275 -- 00:01:07.279 under the safe harbor provisions of the Private Securities Litigation Reform Act. 00:01:07.279 -- 00:01:11.923 I caution listeners that management will be making forward-looking statements. 00:01:11.923 -- 00:01:17.207 Actual results could differ materially from those stated or implied by our forward-looking 00:01:17.207 -- 00:01:22.391 statements due to the risks and uncertainties associat...